Home LiteratureArticle Details
PMID: 932197 Published · ppublish English Case Reports Journal Article Research Support, U.S. Gov't, P.H.S.

Hereditary deficiency of the fifth component of complement in man. I. Clinical, immunochemical, and family studies.

The Journal of clinical investigation ·Vol. 57 ·No. 6 ·1976-06-00 ·Pages 1626-34

Rosenfeld SI, Kelly ME, Leddy JP

Abstract

The first recognized human kindred with hereditary deficiency of the fifth component of complement (C5) is described. The proband, a 20-year-old black female with systemic lupus erythematosus since age 11, lacked serum hemolytic complement activity, even during remission. C5 was undetectable in her serum by both immunodiffusion and hemolytic assays. Other complement components were normal during remission of lupus, but C1, C4, C2, and C3 levels fell during exacerbations. A younger half-sister, who had no underlying disease, was also found to lack immunochemically detectable C5. By hemolytic assay, she exhibited 1-2% of the normal serum C5 level and normal concentrations of other complement components. C5 levels of other family members were either normal or approximately half-normal, consistent with autosomal codominant inheritance of the gene determining C5 deficiency. Normal hemolytic titers were restored to both homozygous C5-deficient (C5D) sera by addition of highly purified human C5. In specific C5 titrations, however, it was noted that when limited amounts of C5 were assayed in the presence of low dilutions of either C5D serum, curving rather than linear dose-response plots were consistently obtained, suggesting some inhibitory effect. Further studies suggested that low dilutions of C5D serum contain a factor (or factors) interfering at some step in the hemolytic assay of C5, rather than a true C5 inhibitor or inactivator. Of clinical interest are (a) the documentation of membranous glomerulonephritis, vasculitis, and arthritis in an individual lacking C5 (and its biologic functions), and (b) a remarkable propensity to bacterial infections in the proband, even during periods of low-dose or alternate-day corticosteroid therapy. Other observations indicate that the C5D state is compatible with normal coagulation function and the capacity to mount a neutrophilic leukocytosis during pyogenic infection.

MeSH Terms
Adult Child Complement C5/antagonists & inhibitors,deficiency Complement System Proteins/deficiency Female Hemolysis Humans Immunologic Deficiency Syndromes/genetics,immunology Pedigree
Chemicals
Complement C5 Complement System Proteins
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Rosenfeld S I
Kelly M E
Leddy J P
References (24)
24 references, click to expand
  1. The C3-activator system: an alternate pathway of complement activation.
    J Exp Med. 1971 Sep 1;134(3 Pt 2):90s-108s PMID: 4105810
  2. The complement system of man. I.
    N Engl J Med. 1972 Sep 7;287(10):489-95 PMID: 4114930
  3. Additional studies on human C5: development of a modified purification method and characterization of the purified product by polyacrylamide gel electrophoresis.
    Immunochemistry. 1972 Jul;9(7):709-23 PMID: 4261220
  4. Heat labile opsonins to pneumococcus. II. Involvement of C3 and C5.
    J Exp Med. 1969 Dec 1;130(6):1229-41 PMID: 4390900
  5. Evidence for linkage between HL-A histocompatibility genes and those involved in the synthesis of the second component of complement.
    J Exp Med. 1974 Oct 1;140(4):1108-11 PMID: 4427089
  6. Enharncement of the hemolytic activity of the second component of human complement by oxidation.
    J Exp Med. 1967 Dec 1;126(6):1013-25 PMID: 4964564
  7. Role of C5 in the nephritis of NZB-W mice.
    J Immunol. 1971 Mar;106(3):740-6 PMID: 4993865
  8. Immune hemolysis. I. Differing susceptibility of three genetic types of sheep red cells.
    J Immunol. 1972 Feb;108(2):467-74 PMID: 5049093
  9. Structural polymorphism of the fourth component of human complement.
    J Clin Invest. 1969 Dec;48(12):2283-92 PMID: 5389795
  10. C3 inactivator of man. I. Hemolytic measurement by the inactivation of cell-bound C3.
    J Immunol. 1969 Mar;102(3):533-43 PMID: 5813010
  11. The role of complement in resistance to endogenous and exogenous infection with a common mouse pathogen, Corynebacterium kutscheri.
    J Exp Med. 1966 Oct 1;124(4):689-99 PMID: 5922289
  12. Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum.
    Immunochemistry. 1966 Mar;3(2):111-35 PMID: 5960883
  13. Three naturally-occurring inhibitors of components of complement in guinea pig and rabbit serum.
    J Immunol. 1967 Sep;99(3):582-9 PMID: 6051385
  14. Hereditary deficiency of the sixth component of complement in man. I. Immunochemical, biologic, and family studies.
    J Clin Invest. 1974 Feb;53(2):544-53 PMID: 11344568
  15. Role of complement during experimental Candida infection in mice.
    Infect Immun. 1971 Apr;3(4):521-3 PMID: 16558009
  16. Complete absence of the third component of complement in man.
    J Clin Invest. 1975 Sep;56(3):703-10 PMID: 1159084
  17. Inherited C2 deficiency and systemic lupus erythematosus: studies on a family.
    Ann Intern Med. 1975 Mar;82(3):323-28 PMID: 46731
  18. Mixed lymphocyte culture determinants and C2 deficiency: LD-7a associated with C2 deficiency in four families.
    J Exp Med. 1975 Aug 1;142(2):495-506 PMID: 124762
  19. Hereditary deficiency of the fifth component of complement in man. II. Biological properties of C5-deficient human serum.
    J Clin Invest. 1976 Jun;57(6):1635-43 PMID: 777027
  20. A case of deficiency of the seventh component of complement in man. Biological properties of a C7-deficient serum and description of a C7-inactivating principle.
    Clin Exp Immunol. 1975 Feb;19(2):223-35 PMID: 813921
  21. Hereditary complement (C2) deficiency with dermatomyositis.
    Am J Med. 1975 Jan;58(1):83-91 PMID: 1090155
  22. Hereditary deficiency of the seventh component of complement.
    J Clin Invest. 1975 Oct;56(4):905-13 PMID: 1099121
  23. Hereditary C2 deficiency: Genetic studies and association with the HL-A system.
    J Exp Med. 1975 Jun 1;141(6):1464-9 PMID: 1127385
  24. Genetic linkage between the HL-A system and a deficit of the second component (C2) of complement.
    Science. 1975 Jun 6;188(4192):1020-2 PMID: 1145185
Article Info
Journal
The Journal of clinical investigation
Abbr.
J Clin Invest
ISSN
0021-9738
Published
1976-06-00
Pages
1626-34
Language
English
Region
United States
NLM ID
7802877
PMCID
PMC436822
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]